User profiles for Jonathan C. M. Wan
 | Jonathan CM WanAcademic Clinical Fellow in Medical Oncology, University College London Verified email at crick.ac.uk Cited by 3843 |
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Improvements in genomic and molecular methods are expanding the range of potential
applications for circulating tumour DNA (ctDNA), both in a research setting and as a 'liquid biopsy…
applications for circulating tumour DNA (ctDNA), both in a research setting and as a 'liquid biopsy…
Enhanced detection of circulating tumor DNA by fragment size analysis
Existing methods to improve detection of circulating tumor DNA (ctDNA) have focused on
genomic alterations but have rarely considered the biological properties of plasma cell-free …
genomic alterations but have rarely considered the biological properties of plasma cell-free …
ctDNA monitoring using patient-specific sequencing and integration of variant reads
Circulating tumor-derived DNA (ctDNA) can be used to monitor cancer dynamics noninvasively.
Detection of ctDNA can be challenging in patients with low-volume or residual disease, …
Detection of ctDNA can be challenging in patients with low-volume or residual disease, …
Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
Glioma‐derived cell‐free DNA (cfDNA) is challenging to detect using liquid biopsy because
quantities in body fluids are low. We determined the glioma‐derived DNA fraction in …
quantities in body fluids are low. We determined the glioma‐derived DNA fraction in …
Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA
Mutational signatures accumulate in somatic cells as an admixture of endogenous and
exogenous processes that occur during an individual’s lifetime. Since dividing cells release cell-…
exogenous processes that occur during an individual’s lifetime. Since dividing cells release cell-…
Survival outcomes of early versus deferred cystectomy for high-grade non-muscle-invasive bladder cancer: a systematic review
JCM Wan - Current Urology, 2020 - karger.com
Background: Studies report that survival outcomes in patients with non-muscle-invasive
bladder cancer (NMIBC) are worse when cystectomy is delayed. However, no systematic …
bladder cancer (NMIBC) are worse when cystectomy is delayed. However, no systematic …
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
Background Cell-free tumor-derived DNA (ctDNA) allows non-invasive monitoring of
cancers, but its utility in renal cell cancer (RCC) has not been established. Methods Here, a …
cancers, but its utility in renal cell cancer (RCC) has not been established. Methods Here, a …
Systematic review of medical student willingness to volunteer and preparedness for pandemics and disasters
…, J Ashcroft, L Alexander, JCM Wan… - Emergency Medicine …, 2022 - emj.bmj.com
Objective This systematic review aimed to estimate the willingness of students to volunteer
during a disaster, and how well-prepared medical students are for volunteering by assessing …
during a disaster, and how well-prepared medical students are for volunteering by assessing …
Detection of ctDNA from dried blood spots after DNA size selection
… Katrin Heider and Jonathan CM Wan contributed equally to this work. … is shown in Wan
et al. (12), as patient 65. Whole blood samples were collected into 9-mL K2-EDTA tubes. …
et al. (12), as patient 65. Whole blood samples were collected into 9-mL K2-EDTA tubes. …
Clinical support during COVID-19: An opportunity for service and learning? A cross-sectional survey of UK medical students
Purpose Medical students providing support to clinical teams during Covid-19 may have
been an opportunity for service and learning. We aimed to understand why the reported …
been an opportunity for service and learning. We aimed to understand why the reported …
